By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Diagnostics firm China Medical Technologies today said its molecular diagnostics sales rose nearly 33 percent year over year in its fiscal second quarter, helping to grow overall revenues about 22 percent.

For the three months ended Sept. 30, the Beijing firm's molecular diagnostics systems segment recorded revenues of RMB118.3 million ($17.8 million), compared to RMB89.2 million in the second quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.